What Synapse Integrative Behavioral Health does

Synapse Integrative Behavioral Health is a privately held outpatient psychiatric practice headquartered at 750 Rt 73 S, Suite 210, Marlton, New Jersey, that began offering services in 2020 as part of the Beacon Behavioral Health Partners network of physician-led clinics. The practice delivers integrated mental health care across the lifespan (children as young as five through adults), combining psychiatric medication management, psychotherapy, ADHD testing, pharmacogenetic testing via a Genesight partnership, and advanced neuromodulation modalities including Transcranial Magnetic Stimulation (TMS) and Spravato (esketamine). It also provides medication-assisted treatment (Suboxone) for opioid use disorder and co-occurring mental health and substance use conditions, with telemedicine delivery via doxy.me for remote evaluations, medication management, and therapy.

The clinical team comprises two board-certified psychiatrists (Dr. Maju Mathews and Dr. Joanne Mathews), six board-certified psychiatric mental health nurse practitioners (PMHNP-BCs), a licensed clinical psychologist (PsyD), and multiple licensed therapists (LCSWs, LPCs, LCADC, LAC) covering trauma-focused care, EMDR, DBT, CBT, substance use treatment, and culturally integrated approaches. The practice is led by Dr. Maju Mathews, an author of three books and over 100 peer-reviewed research papers with prior experience across the UK NHS, Hahnemann Hospital, the FDA, and Pinnacle Behavioral Health. Technology is centered on third-party clinical tools rather than proprietary platforms: TMS and Spravato devices, Genesight pharmacogenetic lab integration, and standard secure-video telemedicine infrastructure.

The business model is professional services fee-for-service billed primarily to commercial insurance, with prior authorization and benefits verification performed in-house. The practice does not participate in Medicaid, requiring self-pay for those patients, and reports payment terms of 14 days from invoice. Revenue streams include psychiatric evaluations, medication management, individual/couples/family/group psychotherapy, TMS treatment courses (typically 20-30 sessions over 4-6 weeks), Spravato supervised administration, ADHD assessments, Suboxone maintenance, and pharmacogenetic testing. Growth is driven by physician referrals, organic Google search, patient reviews, and limited provider-led social media; the practice is in active hiring per its ADP careers portal.

Name

Synapse Integrative Behavioral Health

Legal name

Synapse Behavioral Health

Website

https://synapsebehavioralhealth.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Synapse Integrative Behavioral Health is a Marlton, New Jersey-based outpatient psychiatric practice delivering integrated medication management, psychotherapy, TMS, Spravato, pharmacogenetic testing, and Suboxone treatment to children, adolescents, and adults in South Jersey, operating under the Beacon Behavioral Health Partners network.

Ownership category

akta.pro rank

Headquarters

HQ city

Marlton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Psychiatric Evaluation and Medication Management: Fee-for-service billing for psychiatric evaluations, medication management visits, and ongoing prescription monitoring. Billed by fax and email with payment required within 14 days of invoice submission.
2. Psychotherapy and Counseling Services: Individual, couples, family, and group therapy sessions billed per session. Provided by licensed therapists including LCSWs, LPCs, and LACs.
3. Spravato (Esketamine) Treatment: FDA-approved nasal spray treatment for treatment-resistant depression. Insurance verification is conducted prior to treatment initiation. Part of a structured treatment schedule (twice weekly initially, then weekly).
4. Transcranial Magnetic Stimulation (TMS): Non-invasive brain stimulation treatment for treatment-resistant depression. Most insurance plans cover TMS therapy; prior authorization is obtained from insurance before treatment.
5. Pharmacogenetic Testing: Genesight genetic testing to support medication management. Coverage varies by insurance plan; Genesight works directly with insurance to determine out-of-pocket costs. Self-pay option available if not covered.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Synapse Integrative Behavioral Health operates a physician-led psychiatric practice in Marlton, New Jersey, delivering comprehensive outpatient mental health services including psychiatric evaluations, medication management, individual/family/group psychotherapy, ADHD testing, pharmacogenetic testing (Genesight), Suboxone treatment for opioid use disorder, and advanced neuromodulation therapies such as Transcranial Magnetic Stimulation (TMS) and Spravato (esketamine) for treatment-resistant depression. The practice also provides telemedicine visits for medication management and therapy follow-ups.

Product overview

Synapse Integrative Behavioral Health operates as a physician-led psychiatric practice offering comprehensive mental health services in Marlton, New Jersey. The practice provides an integrated suite of services including Medication Management, TMS (Transcranial Magnetic Stimulation), Spravato (Esketamine), Psychotherapy Counseling, ADHD Testing, Pharmacogenetic Testing (via Genesight), and Suboxone Treatment. The practice also offers Telemedicine Services for remote care delivery. Services address conditions including depression, anxiety disorders, bipolar disorders, trauma and PTSD, ADHD, OCD, pregnancy and postpartum disorders, and treatment-resistant depression. The practice is part of the Beacon Behavioral Health network.

Differentiator

Problem solved

Functional benefit

Products and services

• Medication Management

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• GenesightcoreTechnology or IntegrationSynapse Behavioral Health partners with Genesight, an industry leader in pharmacogenetic testing for mental health medications. Genesight provides cheek-swab DNA testing to identify which psychiatric medications are most compatible with a patient's biology, which may cause side effects, and which to avoid. Results are typically available within 24-72 hours. Genesight handles insurance coordination directly.
• Beacon Behavioral Health PartnerscoreOthersSynapse Behavioral Health is part of a nationwide network of physician-led psychiatric practices driven by Beacon Behavioral Health Partners. Beacon supports growth and innovation in behavioral healthcare, enabling practices to operate under a shared infrastructure while maintaining local patient care delivery. The network aims to create a future where patient care comes first without barriers.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Emerging players

• Two Chairs: Two Chairs operates a hybrid in-person and virtual therapy practice with strong clinical quality branding; relevant peer for Synapse's psychotherapy arm and referral pipeline.
• Cerebral: Cerebral is a national telehealth platform focused on anxiety, depression, and ADHD medication management; competes for the same insured patient seeking convenient psychiatric care but does not offer in-person neuromodulation.
• Brightside Health: Brightside Health is a telehealth psychiatry provider specializing in depression and anxiety treatment with medication management; an emerging digital competitor for Synapse's outpatient medication management line.

Broad incumbents

• LifeStance Health: LifeStance Health is a large publicly-traded outpatient mental health platform providing psychiatric evaluation, medication management, and therapy across 30+ states; competes for the same insured outpatient behavioral health patient that Synapse targets in South Jersey.

Direct peers

• Mindpath Health: Mindpath Health is a multi-state outpatient psychiatric group practice offering medication management, therapy, and TMS; comparable service mix to Synapse with broader geographic reach.
• Geode Health: Geode Health operates a hybrid in-person and virtual outpatient psychiatry model offering medication management, therapy, TMS, and Spravato across multiple U.S. markets — a near-direct parallel to Synapse's integrated neuromodulation-plus-therapy offering.
• Talkiatry: Talkiatry is a national psychiatrist-led telepsychiatry practice offering in-network medication management and psychotherapy; overlaps directly with Synapse's psychiatry-first outpatient model and is scaling rapidly via in-network contracts.
• Apricity Behavioral Health: Apricity is a multi-state outpatient psychiatry and therapy practice; its hybrid in-person/telehealth model and broad insurance acceptance make it a closely comparable growth-stage peer.

Regional players

• Jefferson Health Behavioral Health: Jefferson Health's behavioral health service line offers outpatient psychiatry, therapy, and neuromodulation across the greater Philadelphia/South Jersey region; an incumbent regional competitor for referrals and insured patients.
• Capital Health Behavioral Health: Capital Health operates inpatient and outpatient behavioral health services in central New Jersey, including psychiatry and addiction treatment; a regional incumbent whose catchment partially overlaps Synapse's South Jersey footprint.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Customer concentration

• Instagraminstagram.com/kellygoldennp
• LinkedInlinkedin.com/company/synapse-integrative-behavioral-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synapse Integrative Behavioral Health